You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ponatinib

Showing 26 - 40 of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Gastrointestinal Cancer, Non Small Cell Lung Cancer Trial in Italy (Erlotinib, Trastuzumab, Trastuzumab

Recruiting
  • Breast Cancer
  • +3 more
  • Ancona, Italy
  • +40 more
Jan 25, 2023

Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in China (Ponatinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Ponatinib
  • Hefei, Anhui, China
  • +13 more
Aug 11, 2020

Non Small Cell Lung Cancer Trial in United States (Ponatinib)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Ponatinib
  • Orange, California
  • +4 more
Dec 8, 2019

Leukemia Trial in Houston (Ponatinib)

Terminated
Has Results
  • Leukemia
  • Ponatinib
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 16, 2019

Chronic Myeloid Leukemia Trial in Spain (Ponatinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Ponatinib
  • Badalona, Barcelona, Spain
  • +8 more
Aug 1, 2019

Glioblastoma Trial in Boston (Ponatinib)

Completed
Has Results
  • Glioblastoma
  • Ponatinib
  • Boston, Massachusetts
  • +1 more
Jun 25, 2018

GIST Trial in Boston, Portland, Philadelphia (Ponatinib)

Completed
Has Results
  • GIST
  • Ponatinib
  • Boston, Massachusetts
  • +3 more
Apr 17, 2018

Chronic Myelogenous Leukemia, Hematologic Malignancies Trial in United States (Ponatinib)

Completed
  • Chronic Myelogenous Leukemia
  • Hematologic Malignancies
  • Ponatinib
  • San Francisco, California
  • +4 more
May 15, 2018

Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Trial in United States

Approved for marketing
  • Chronic Myeloid Leukemia (CML)
  • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
  • ponatinib
  • La Jolla, California
  • +32 more
Feb 5, 2018

Leukemia, FLT3-Mutated Acute Myeloid Leukemia, FLT3-Mutated High-Risk Myelodysplastic Syndrome Trial (Ponatinib, 5-azacytidine,

Withdrawn
  • Leukemia
  • +2 more
  • Ponatinib
  • +2 more
  • (no location specified)
Jun 1, 2017

Thyroid Tumors Trial run by the CC (Ponatinib)

Terminated
Has Results
  • Thyroid Neoplasms
  • Ponatinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 30, 2016

Endometrial Tumors Trial (Ponatinib)

Withdrawn
  • Endometrial Neoplasms
  • Ponatinib
  • (no location specified)
Dec 17, 2015

NSCLC, Head Neck Cancer Trial in Boston (ponatinib)

Terminated
Has Results
  • Non-Small Cell Lung Cancer, Head and Neck Cancer
  • ponatinib
  • Boston, Massachusetts
  • +3 more
Dec 13, 2014

Chronic Myeloid Leukemia Trial in Worldwide (ponatinib, imatinib (Gleevec/ Glivec))

Terminated
Has Results
  • Chronic Myeloid Leukemia
  • ponatinib
  • imatinib (Gleevec/ Glivec)
  • Burbank, California
  • +169 more
Nov 5, 2014

Philadelphia Chromosome Positive (Ph+) Leukemias, Chronic Myeloid Leukemia Trial in Portland (Ponatinib)

No longer available
  • Philadelphia Chromosome Positive (Ph+) Leukemias
  • Chronic Myeloid Leukemia
  • Ponatinib
  • Portland, Oregon
    OHSU Knight Cancer Institute
Mar 13, 2013